Literature DB >> 12135853

Urinary tract infection in patients with neurogenic bladder dysfunction.

D Sauerwein1.   

Abstract

Recurrent urinary tract infections (UTI) are a significant problem in all patients with neurogenic bladder leading to high morbidity, poor quality of life and a limited life expectancy. For the diagnosis of UTI, a urine specimen taken by bladder puncture or catheterization is required. In patients with neurogenic bladders, clinical symptoms and leukocyturia must be present together with bacteriuria in order to qualify as UTI. The spectrum of pathogens differs significantly from that in patients with normal bladder function. Culture and antimicrobial susceptibility testing must, therefore, be performed prior to the initiation of antibiotic therapy. This is also important in the prevention of the emergence of antimicrobial resistance. The main way to prevent recurrent UTI in the neurogenic bladder is by restoring the normal low-pressure reservoir function of the bladder and is the aim of neuro-urological management.

Entities:  

Mesh:

Year:  2002        PMID: 12135853     DOI: 10.1016/s0924-8579(02)00114-0

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  8 in total

1.  Retrospective study for risk factors for febrile UTI in spinal cord injury patients with routine concomitant intermittent catheterization in outpatient settings.

Authors:  S Mukai; K Shigemura; M Nomi; A Sengoku; F Yamamichi; M Fujisawa; S Arakawa
Journal:  Spinal Cord       Date:  2015-10-13       Impact factor: 2.772

2.  Management of febrile urinary tract infection among spinal cord injured patients.

Authors:  Aurélien Dinh; Adnène Toumi; Constance Blanc; Alexis Descatha; Frédérique Bouchand; Jérôme Salomon; Thomas Hanslik; Benjamin Bernuz; Pierre Denys; Louis Bernard
Journal:  BMC Infect Dis       Date:  2016-04-16       Impact factor: 3.090

Review 3.  Congenital causes of neurogenic bladder and the transition to adult care.

Authors:  Christopher J Loftus; Hadley M Wood
Journal:  Transl Androl Urol       Date:  2016-02

4.  Efficacy and Adverse Events Associated With Use of OnabotulinumtoxinA for Treatment of Neurogenic Detrusor Overactivity: A Meta-Analysis.

Authors:  Hejia Yuan; Yuanshan Cui; Jitao Wu; Peng Peng; Xujie Sun; Zhenli Gao
Journal:  Int Neurourol J       Date:  2017-03-24       Impact factor: 2.835

5.  In Patients with Neurogenic Detrusor Overactivity and Hinman's Syndrome: Would Intravesical Botox Injections Decrease the Incidence of Symptomatic Urinary Tract Infections.

Authors:  Mai Banakhar; Ahmed Yamani
Journal:  Res Rep Urol       Date:  2021-09-02

6.  Management of lower urinary tract dysfunction in patients with neurological disorders.

Authors:  Wen Ji Li; Seung-June Oh
Journal:  Korean J Urol       Date:  2012-09-19

7.  The effect of spinal cord-injury level on the outcome of neurogenic bladder treatment using OnabotulinumtoxinA.

Authors:  Waleed Al Taweel; Khalil Mohammed Alzyoud
Journal:  Urol Ann       Date:  2015 Jul-Sep

8.  Prevalence of Urinary Tract Infection and Antimicrobial Susceptibility among Diabetic Patients with Controlled and Uncontrolled Glycemia in Kuwait.

Authors:  May Sewify; Shinu Nair; Samia Warsame; Mohamed Murad; Asma Alhubail; Kazem Behbehani; Faisal Al-Refaei; Ali Tiss
Journal:  J Diabetes Res       Date:  2015-12-30       Impact factor: 4.011

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.